Update CSV files

Author: actions-user

Decline.csv

@@ -16,7 +16,6 @@ Dabrafenib,/apptracker/s/application-public/a102P000008pu2y,"Melanoma, stage III
 Deflazacort,/apptracker/s/application-public/a102P000008pujy,Duchenne muscular dystrophy,Musculoskeletal System
 Desmopressin,/apptracker/s/application-public/a10OZ000000qI8v,"Arginine vasopressin deficiency (previously central diabetes insipidus), 60mcg and 240mcg desmopressin wafers for dose titration",
 Dexcom G5 Continuous Glucose Monitors,/apptracker/s/application-public/a102P00000BBg62,Type 2 diabetes,Alimentary Tract and Metabolism
-Diflunisal,/apptracker/s/application-public/a102P00000ABk8y,ATTRwt induced cardiomyopathy,Blood and Blood Forming Organs
 Dostarlimab-gxly,/apptracker/s/application-public/a10OZ000002WKQf,"endometrial cancer, treatment of advanced or recurrent, irrespective of dMMR status, second line",
 Dupilumab,/apptracker/s/application-public/a102P00000BMJQf,"Moderate to severe atopic dermatitis, following 2nd line treatment(s)",Dermatologicals
 Dupilumab,/apptracker/s/application-public/a102P00000BMh6q,"Chronic rhinosinusitis with nasal polyposis (CRSwNP), maintenance treatment of uncontrolled disease",Respiratory System and Allergies

OFI.csv

@@ -15,6 +15,7 @@ Atogepant,/apptracker/s/application-public/a10OZ00000019Fl,Prophylaxis of chroni
 Benralizumab,/apptracker/s/application-public/a102P00000BNz5p,"Eosinophilic asthma, ACT and >300 cells/ul eosinophil count criteria (widening access)",Oncology Agents and Immunosuppressants
 Bevacizumab,/apptracker/s/application-public/a102P000008ptpo,"Metastatic colorectal cancer , neoadjuvant treatment for metastatic disease confined to the liver",Oncology Agents and Immunosuppressants
 Bevacizumab,/apptracker/s/application-public/a102P000008ptxU,"Cervical cancer, advanced",Oncology Agents and Immunosuppressants
+Brentuximab vedotin,/apptracker/s/application-public/a10OZ0000000hzR,Previously untreated systemic anaplastic large-cell lymphoma (sALCL),Oncology Agents and Immunosuppressants
 Bruton tyrosine kinase inhibitor (BTKi),/apptracker/s/application-public/a10OZ000000LuVR,"chronic lymphocytic leukaemia, first line monotherapy, with TP53 mutation",
 Budesonide controlled-release,/apptracker/s/application-public/a102P000008pu9g,"Ulcerative colitis, mild to moderately active",Alimentary Tract and Metabolism
 Budesonide orodispersible tablets,/apptracker/s/application-public/a102P00000BY17Q,"Eosinophilic oesophagitis, 2nd line after fluticasone",Alimentary Tract and Metabolism
@@ -72,7 +73,9 @@ Nab-paclitaxel,/apptracker/s/application-public/a102P00000BQdRd,"Metastatic brea
 Nab-paclitaxel,/apptracker/s/application-public/a102P00000BX13e,"Metastatic breast cancer, following grade 3+ hypersensitivity reaction on paclitaxel",Oncology Agents and Immunosuppressants
 Nitisinone,/apptracker/s/application-public/a102P000008ptrM,Tyrosinaemia Type 1,Alimentary Tract and Metabolism
 Non-latex condoms,/apptracker/s/application-public/a102P000008puaC,Sexually transmitted infection (STI) prevention and contraception in patients with latex allergies,Genito-Urinary System
+Onasemnogene abeparvovec,/apptracker/s/application-public/a102P00000BY8r2,"Spinal muscular atrophy (SMA), pre-symptomatic or type 1",Nervous System
 Oral feed 1.5k cal/ml liquid ONS,/apptracker/s/application-public/a102P000008ptz6,Head and Neck Cancer,Special Foods
+Pegunigalsidase alfa-iwxj,/apptracker/s/application-public/a10OZ00000466q1,Fabry Disease,
 Pembrolizumab,/apptracker/s/application-public/a102P00000BajR0,Biliary tract cancer,Oncology Agents and Immunosuppressants
 Perampanel,/apptracker/s/application-public/a102P00000AlVHF,Focal epilepsy,Nervous System
 Pertuzumab (IV form),/apptracker/s/application-public/a102P000008ptqk,"Breast cancer, HER2-positive, locally advanced, inflammatory or early-stage, neoadjuvant treatment",Oncology Agents and Immunosuppressants